Health Care
Bbg Advanced Therapies
SAN ANTONIO, TX
Total revenue
$5.4M
Total expenses
$16.0M
Net assets
—
Grants received
$496K
2 grants
EIN
462216869
Tax year
2024
Mission
GenCure enables progress in the field of advanced therapies (also known as cell & gene therapies) by offering process and analytical (CONTINUED ON SCHEDULE O)
Financials
FY 2024
Revenue
Expenses
People
7 listed
BIOBRIDGE GLOBAL
SOLE MEMBER
—
1 hrs/wk
GEOFFREY KINDT
General Manager, Biomanufacturing (thru 11/02/2024)
$261K
50 hrs/wk
ROGELIO ZAMILPA
Executive Director, Biomanufacturing & Collab
$215K
50 hrs/wk
MARI LANE SALMI
SR. DIRECTOR, PROCESS DEV & CELL THERAPIES
$203K
50 hrs/wk
MILTON MASAYUKI POLLARD
VP, GENCURE OPERATIONS (thru 07/09/2024)
$196K
50 hrs/wk
Miguel Garza
Director, Operations Biomanufacturing
$156K
50 hrs/wk
AMANDA WHITELONIS
Principal Global Market Development (effective 11/03/2024)
$20K
50 hrs/wk
Independent contractors
CAM PHARMACEUTICAL CONSULTING LLC
BIOTECH CONSULTING SERVICES
Grants received
Showing 2 of 2
Funded by
$496K from 2 funders · 2 grants · 2017–2020
$250K · 1 grant · 2017
$246K · 1 grant · 2020